Clinical Trial Results: A Study of TAK-103 in Adult With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of TAK-103 in adults with solid tumors; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TAK-103

Snippet

Sponsor: Takeda | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2026-07-07